ClearBridge Investments’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,000
| Closed | -$4K | – | 1020 |
|
|
2020
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 929 |
|
|
2020
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1021 |
|
|
2019
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1071 |
|
|
2019
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1086 |
|
|
2019
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1089 |
|
|
2019
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1056 |
|
|
2018
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1118 |
|
|
2018
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1114 |
|
|
2018
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1081 |
|
|
2018
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1066 |
|
|
2017
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1095 |
|
|
2017
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1137 |
|
|
2017
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1146 |
|
|
2017
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1106 |
|
|
2016
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1145 |
|
|
2016
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1100 |
|
|
2016
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1044 |
|
|
2016
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1046 |
|
|
2015
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1091 |
|
|
2015
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1146 |
|
|
2015
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1148 |
|
|
2015
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1165 |
|
|
2014
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1166 |
|
|
2014
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 1147 |
|
|
2014
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 1153 |
|
|
2014
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 1112 |
|
|
2013
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 1074 |
|
|
2013
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 1048 |
|
|
2013
Q2 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 1045 |
|